Latest Insider Transactions at Eastman Chemical CO (EMN)
This section provides a real-time view of insider transactions for Eastman Chemical CO (EMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EASTMAN CHEMICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EASTMAN CHEMICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 04
2023
|
David W Raisbeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+3.25%
|
-
|
May 04
2023
|
James J /Ky Obrien Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+35.37%
|
-
|
May 04
2023
|
Julie Fasone Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+9.52%
|
-
|
Apr 13
2023
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-13.25%
|
$462,808
$83.38 P/Share
|
Apr 13
2023
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
18,701
+30.77%
|
-
|
Feb 28
2023
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-10.34%
|
$15,725
$85.2 P/Share
|
Feb 28
2023
|
Michelle Renee Stewart Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
665
+27.09%
|
-
|
Feb 17
2023
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Open market or private sale
|
Direct |
1,900
-39.77%
|
$163,400
$86.89 P/Share
|
Feb 15
2023
|
Mark J Costa CEO & Board Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
34,891
-8.53%
|
$3,105,299
$89.09 P/Share
|
Feb 15
2023
|
Mark J Costa CEO & Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
92,916
+18.52%
|
-
|
Feb 15
2023
|
Stephen Glenn Crawford EVP, Manf. & Chf Sustain Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,849
-8.81%
|
$342,561
$89.09 P/Share
|
Feb 15
2023
|
Stephen Glenn Crawford EVP, Manf. & Chf Sustain Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
14,035
+24.31%
|
-
|
Feb 15
2023
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-14.86%
|
$74,226
$89.09 P/Share
|
Feb 15
2023
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
3,343
+37.34%
|
-
|
Feb 15
2023
|
Brian Travis Smith SVP, Add & Funct Prod |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-22.74%
|
$95,764
$89.09 P/Share
|
Feb 15
2023
|
Brian Travis Smith SVP, Add & Funct Prod |
BUY
Grant, award, or other acquisition
|
Direct |
3,597
+43.19%
|
-
|
Feb 15
2023
|
Christopher Moore Killian SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-8.92%
|
$80,456
$89.09 P/Share
|
Feb 15
2023
|
Christopher Moore Killian SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
3,631
+26.37%
|
-
|
Feb 15
2023
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-17.34%
|
$21,004
$89.09 P/Share
|
Feb 15
2023
|
Michelle Renee Stewart Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
665
+32.82%
|
-
|
Feb 15
2023
|
William Thomas Mc Lain Jr. EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,044
-12.48%
|
$359,916
$89.09 P/Share
|
Feb 15
2023
|
William Thomas Mc Lain Jr. EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,519
+30.94%
|
-
|
Feb 15
2023
|
Brad A Lich EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,471
-12.64%
|
$664,919
$89.09 P/Share
|
Feb 15
2023
|
Brad A Lich EVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
23,229
+28.21%
|
-
|
Oct 17
2022
|
Brian Travis Smith SVP, Add & Funct Prod |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-33.82%
|
$42,340
$73.94 P/Share
|
Oct 17
2022
|
Brian Travis Smith SVP, Add & Funct Prod |
BUY
Exercise of conversion of derivative security
|
Direct |
1,715
+50.0%
|
-
|
Oct 17
2022
|
Christopher Moore Killian SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
675
-9.48%
|
$49,275
$73.94 P/Share
|
Oct 17
2022
|
Christopher Moore Killian SVP & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,715
+19.4%
|
-
|
May 05
2022
|
Charles K. Stevens Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+22.22%
|
-
|
May 05
2022
|
David W Raisbeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+2.52%
|
-
|
May 05
2022
|
Julie Fasone Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+8.06%
|
-
|
May 03
2022
|
Lucian Boldea Executive VP |
SELL
Open market or private sale
|
Direct |
10,500
-32.27%
|
$1,071,000
$102.86 P/Share
|
Apr 13
2022
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,253
-23.68%
|
$783,324
$108.39 P/Share
|
Apr 13
2022
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
18,701
+37.91%
|
-
|
Mar 01
2022
|
Brad A Lich EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,346
-6.13%
|
$267,444
$114.6 P/Share
|
Mar 01
2022
|
Brad A Lich EVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,961
+13.49%
|
-
|
Feb 28
2022
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-15.12%
|
$14,632
$118.47 P/Share
|
Feb 28
2022
|
Michelle Renee Stewart Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
446
+35.23%
|
-
|
Feb 28
2022
|
Mark K Cox SVP, Chf Mfg & Eng Ofc |
SELL
Bona fide gift
|
Direct |
845
-24.08%
|
-
|
Feb 25
2022
|
Mark K Cox SVP, Chf Mfg & Eng Ofc |
SELL
Open market or private sale
|
Direct |
4,858
-58.06%
|
$582,960
$120.79 P/Share
|
Feb 23
2022
|
Lucian Boldea Executive VP |
SELL
Payment of exercise price or tax liability
|
Direct |
6,427
-16.49%
|
$764,813
$119.03 P/Share
|
Feb 23
2022
|
Lucian Boldea Executive VP |
BUY
Grant, award, or other acquisition
|
Direct |
19,526
+33.38%
|
-
|
Feb 23
2022
|
William Thomas Mc Lain Jr. EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
746
-4.0%
|
$88,774
$119.03 P/Share
|
Feb 23
2022
|
William Thomas Mc Lain Jr. EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,073
+14.16%
|
-
|
Feb 23
2022
|
Brad A Lich EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,242
-18.32%
|
$861,798
$119.03 P/Share
|
Feb 23
2022
|
Brad A Lich EVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
21,582
+35.32%
|
-
|
Feb 23
2022
|
Christopher Moore Killian SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-15.66%
|
$117,334
$119.03 P/Share
|
Feb 23
2022
|
Christopher Moore Killian SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
4,047
+39.13%
|
-
|
Feb 23
2022
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-35.52%
|
$24,514
$119.03 P/Share
|
Feb 23
2022
|
Michelle Renee Stewart Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
580
+50.0%
|
-
|